---
document_datetime: 2024-06-04 13:04:20
document_pages: 14
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/onpattro-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: onpattro-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 6.9737158
conversion_datetime: 2025-12-31 03:31:40.188817
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Onpattro

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                                                                  | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0039              | C.I.1.b - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a Union referral procedure - The product is not covered by the defined scope of the procedure but the change(s) implements the outcome of the procedure and no new additional data is required to be submitted by | 31/05/2024                          |                                             | SmPC and PL                      |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                     | the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |            |     |                                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| PSUSA/10715 /202308 | Periodic Safety Update EU Single assessment - patisiran                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 07/03/2024 | n/a | PRAC Recommendation - maintenance |
| IA/0037/G           | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient | 05/03/2024 | n/a |                                   |
| IA/0036             | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient                                                                                                                                                                                                                                                                                                 | 05/03/2024 | n/a |                                   |
| II/0034             | Submission of the final study report from a category 3 study in the RMP and updates to the RMP. C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority                                                                                                                                                                                                                                                                                                | 08/02/2024 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

| PSUSA/10715 /202208   | Periodic Safety Update EU Single assessment - patisiran                                                                                                                                                                                               | 30/03/2023   | 26/05/2023   | SmPC and PL   | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10715/202208.   |
|-----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|---------------|----------------------------------------------------------------------------------------------------------------------------------------------|
| R/0031                | Renewal of the marketing authorisation.                                                                                                                                                                                                               | 23/02/2023   | 04/04/2023   |               |                                                                                                                                              |
| IAIN/0033             | B.I.a.1.a - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The proposed manufacturer is part of the same pharmaceutical group as the currently approved manufacturer                                        | 21/03/2023   | n/a          |               |                                                                                                                                              |
| IB/0032               | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                         | 23/01/2023   | n/a          |               |                                                                                                                                              |
| II/0025               | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                     | 12/01/2023   | 04/04/2023   | SmPC          |                                                                                                                                              |
| IA/0029               | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                      | 17/10/2022   | n/a          |               |                                                                                                                                              |
| IAIN/0028/G           | This was an application for a group of variations. B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - | 05/10/2022   | n/a          |               |                                                                                                                                              |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |            |     |             |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------|
| II/0027/G | This was an application for a group of variations. B.II.c.1.d - Change in the specification parameters and/or limits of an excipient - Change outside the approved specifications limits range B.II.c.z - Change in control of excipients in the Finished Product - Other variation B.II.c.1.a - Change in the specification parameters and/or limits of an excipient - Tightening of specification limits B.II.b.3.b - Change in the manufacturing process of the finished or intermediate product - Substantial changes to a manufacturing process that may have a significant impact on the quality, safety and efficacy of the medicinal product B.II.c.4.a - Change in synthesis or recovery of a non- pharmacopoeial or novel excipient - Minor change A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) B.II.c.z - Change in control of excipients in the Finished Product - Other variation B.II.c.2.d - Change in test procedure for an excipient - Other changes to a test procedure (including | 01/09/2022 | n/a | replacement |

<div style=\"page-break-after: always\"></div>

|                     | B.II.c.z - Change in control of excipients in the Finished Product - Other variation B.II.c.z - Change in control of excipients in the Finished Product - Other variation B.II.c.z - Change in control of excipients in the Finished Product - Other variation B.II.c.z - Change in control of excipients in the Finished Product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |            |     |                                   |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| IB/0026/G           | This was an application for a group of variations. B.II.b.5.f - Change to in-process tests or limits applied during the manufacture of the finished product - Addition or replacement of an in-process test as a result of a safety or quality issue B.II.b.5.f - Change to in-process tests or limits applied during the manufacture of the finished product - Addition or replacement of an in-process test as a result of a safety or quality issue B.I.a.4.a - Change to in-process tests or limits applied during the manufacture of the AS - Tightening of in-process limits B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.I.a.4.a - Change to in-process tests or limits applied during the manufacture of the AS - Tightening of in-process limits | 17/05/2022 | n/a |                                   |
| PSUSA/10715 /202108 | Periodic Safety Update EU Single assessment - patisiran                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 10/03/2022 | n/a | PRAC Recommendation - maintenance |

<div style=\"page-break-after: always\"></div>

| IA/0024/G   | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 23/02/2022   | n/a        |             |                                                                               |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|-------------------------------------------------------------------------------|
| II/0022     | Type II variation C.I.4 in the Summary of Product Characteristics (SmPC), Labelling or Package Leaflet (PL) due to new quality, preclinical, clinical or pharmacovigilance data: update of sections 4.2, 4.8, 5.1 and 5.2 of the SmPC to confirm that the safety profile of pasitiran in liver transplant recipients is comparable to data in patients without liver transplant, based on final results from study ALN- TTR02-008, a global phase 3b, open-label, extension study to evaluate safety, efficacy and pharmacokinetics of patisiran in patients with hereditary transthyretin-mediated amyloidosis (HATTR amyloidosis) with disease progression post- orthotopic liver transplant (OLT). The RMP version 1.1 has also been submitted. In addition, the MAH took the opportunity to make some minor changes to the English PI in SmPC section 5.1, 6.3 (In line with EMA recommendation from procedure EMEA/H/C/004699/IB/0014), PL section 2 (minor typographical error changes), 6 (update to contact numbers of local MAH representatives in Cyprus and Malta, and MAH local representative from 'United | 16/12/2021   | 28/11/2022 | SmPC and PL | For more information, please refer to the Summary of Product Characteristics. |

<div style=\"page-break-after: always\"></div>

|           | line with the QRD template version 10.2) and implement minor linguistic changes and typographical error corrections in the Italian PI translation. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |            |     |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| II/0021/G | This was an application for a group of variations. B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range B.I.b.1.f - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Change outside the approved specifications limits range for the AS B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits | 07/10/2021 | n/a |

<div style=\"page-break-after: always\"></div>

| and/or limits of the finished specification limits B.II.d.1.a - Change in and/or limits of the finished specification limits B.II.d.1.a - Change in and/or limits of the finished specification limits B.II.d.1.a - Change in and/or limits of the finished specification limits B.II.b.5.e - Change to applied during the manufacture product - Widening of may have a significant finished product B.II.b.5.a - Change to applied during the manufacture product - Tightening of B.II.b.5.a - Change to applied during the manufacture product - Tightening of B.II.b.5.a - Change to applied during the manufacture product - Tightening of B.II.b.5.a - Change to applied during the manufacture product - Tightening of B.II.b.5.a - Change to applied during the manufacture product - Tightening of   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|                     | and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range B.II.c.1.a - Change in the specification parameters and/or limits of an excipient - Tightening of specification limits B.II.b.5.e - Change to in-process tests or limits applied during the manufacture of the finished product - Widening of the approved IPC limits, which may have a significant effect on overall quality of the finished product B.I.b.1.f - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Change outside the approved specifications limits range for the AS B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of   |            |     |                                   |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| PSUSA/10715 /202102 | Periodic Safety Update EU Single assessment - patisiran                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 02/09/2021 | n/a | PRAC Recommendation - maintenance |
| IA/0020/G           | This was an application for a group of variations. B.II.c.2.a - Change in test procedure for an excipient                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 18/06/2021 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

|                     | - Minor changes to an approved test procedure B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                     |            |     |                                   |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| IA/0019/G           | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.a.4.a - Change to in-process tests or limits applied during the manufacture of the AS - Tightening of in-process limits | 30/04/2021 | n/a |                                   |
| PSUSA/10715 /202008 | Periodic Safety Update EU Single assessment - patisiran                                                                                                                                                                                                                                                                                                                                                                                                | 11/03/2021 | n/a | PRAC Recommendation - maintenance |
| IA/0017/G           | This was an application for a group of variations. B.I.b.2.c - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure for a reagent, which does not have a significant effect on the overall quality of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                 | 06/01/2021 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

| PSUSA/10715 /202002   | Periodic Safety Update EU Single assessment - patisiran                                                                                                                                                                                                  | 17/09/2020   | 20/11/2020   | SmPC and PL                      | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10715/202002.   |
|-----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------|
| IAIN/0016/G           | This was an application for a group of variations. A.1 - Administrative change - Change in the name and/or address of the MAH A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release | 10/11/2020   | 11/10/2021   | SmPC, Annex II, Labelling and PL |                                                                                                                                              |
| IB/0014               | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                | 14/10/2020   | 11/10/2021   | SmPC                             |                                                                                                                                              |
| IAIN/0013/G           | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                      | 28/07/2020   | 20/11/2020   | Annex II and PL                  |                                                                                                                                              |
| PSUSA/10715 /201908   | Periodic Safety Update EU Single assessment - patisiran                                                                                                                                                                                                  | 26/03/2020   | 20/05/2020   | SmPC and PL                      | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10715/201908.   |
| II/0011/G             | This was an application for a group of variations. B.I.a.4.c - Change to in-process tests or limits applied during the manufacture of the AS - Deletion of a non-significant in-process test                                                             | 12/03/2020   | n/a          |                                  |                                                                                                                                              |

<div style=\"page-break-after: always\"></div>

|           | B.I.a.4.d - Change to in-process tests or limits applied during the manufacture of the AS - Widening of the approved in-process test limits, which may have a significant effect on the overall quality of the AS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |            |     |          |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------|
| IB/0010/G | This was an application for a group of variations. B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished product - Tightening of in-process limits B.II.c.z - Change in control of excipients in the Product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                         | 10/01/2020 | n/a | Finished |
| IB/0008/G | This was an application for a group of variations. A.z - Administrative change - Other variation B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.1.c - Change in the specification parameters limits of an AS, starting | 10/12/2019 | n/a | and/or   |

<div style=\"page-break-after: always\"></div>

|                     | material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.I.b.2.z - Change in test procedure for AS or starting material/reagent/intermediate - Other variation   |            |            |             |                                   |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-----------------------------------|
| PSUSA/10715 /201902 | Periodic Safety Update EU Single assessment - patisiran                                                                                                                                                                                                                                                                                                                                                                                                         | 05/09/2019 | n/a        |             | PRAC Recommendation - maintenance |
| IA/0007             | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                                                                                                                | 31/07/2019 | n/a        |             |                                   |
| II/0004/G           | This was an application for a group of variations. B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                   | 25/07/2019 | n/a        |             |                                   |
| IB/0006             | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                                       | 19/07/2019 | 09/03/2020 | SmPC and PL |                                   |

<div style=\"page-break-after: always\"></div>

| IAIN/0003/G   | This was an application for a group of variations. A.6 - Administrative change - Change in ATC Code/ATC Vet Code A.7 - Administrative change - Deletion of manufacturing sites B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing   | 04/04/2019   | 09/03/2020   | SmPC, Annex II, Labelling and PL   |
|---------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------------------|
| IAIN/0002     | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                                                  | 14/12/2018   | n/a          |                                    |
| N/0001        | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                        | 09/11/2018   | 09/03/2020   | PL                                 |